The Effect of Reflective Breathing Therapy Compared With Conventional Breathing Therapy in Patients With Chronic Obstructive Pulmonary Disease (COPD) III-IV; part2
2 other identifiers
interventional
44
1 country
1
Brief Summary
The purpose of this study is to determine whether different types of breathing therapies in patients with COPD III-IV decrease dyspnea, increase activity and have impact on parasympathetic activities.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable chronic-obstructive-pulmonary-disease
Started Jan 2016
Longer than P75 for not_applicable chronic-obstructive-pulmonary-disease
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
July 19, 2013
CompletedFirst Posted
Study publicly available on registry
July 23, 2013
CompletedStudy Start
First participant enrolled
January 1, 2016
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2019
CompletedStudy Completion
Last participant's last visit for all outcomes
March 1, 2020
CompletedJune 18, 2019
June 1, 2019
3.9 years
July 19, 2013
June 17, 2019
Conditions
Outcome Measures
Primary Outcomes (1)
Change in BORG-Scale
Instrument for self-reported dyspnea; modified BORG-scale ranges from 1 (no dyspnea) to 10 (maximum dyspnea)
Change from pre (minute 0) in Borg Scale and directly post intervention
Secondary Outcomes (5)
Change in lung volume
change from pre (minute0) in residual volume to post intervention
physical activity
48 h post intervention
parasympathetic activities
baseline and post intervention
Chronic Respiratory Questionnaire
baseline and post intervention
COPD Assessment Test
baseline and post intervention
Study Arms (2)
Conventional breathing therapy
EXPERIMENTALfirst: conventional breathing therapy, second: reflectory breathing therapy
Reflectory breathing therapy
EXPERIMENTALfirst: Reflectory breathing therapy second:Conventional breathing therapy
Interventions
Eligibility Criteria
You may qualify if:
- inpatient rehabilitation
- COPD (Gold stage III and IV)
You may not qualify if:
- severe exacerbation in the last four weeks
- acute infections
- fever
- neuritides
- severe osteoporosis
- skin disease
- manic depression
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Schön Klinik Berchtesgadener Land
Schönau, Bavaria, 83471, Germany
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY CHAIR
Klaus Kenn, Prof. Dr.
Schön Klinik Berchtesgadener Land
- PRINCIPAL INVESTIGATOR
Tessa Schneeberger
Schön Klinik Berchtesgadener Land
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- CROSSOVER
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Head physician (department of pulmonology)
Study Record Dates
First Submitted
July 19, 2013
First Posted
July 23, 2013
Study Start
January 1, 2016
Primary Completion
December 1, 2019
Study Completion
March 1, 2020
Last Updated
June 18, 2019
Record last verified: 2019-06